Richard Ferrari - Apr 26, 2022 Form 3 Insider Report for Tenon Medical, Inc. (TNON)

Role
Director
Signature
/s/ Richard Ferrari
Stock symbol
TNON
Transactions as of
Apr 26, 2022
Transactions value $
$0
Form type
3
Date filed
4/26/2022, 09:31 PM
Previous filing
Nov 15, 2021
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNON Common Stock 158K Apr 26, 2022 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNON Stock Options Apr 26, 2022 Common Stock 161K $7.06 Direct F2, F3
holding TNON Stock Options Apr 26, 2022 Common Stock 113K $5.20 Direct F4, F5
holding TNON Stock Options Apr 26, 2022 Common Stock 13.7K $0.62 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 65,918 shares held by TCTIG, LLC for which Richard Ferrari has a 25% equity interest therein and has control over how TCTIG, LLC will vote 25% of the shares of common stock held by TCTIG, LLC and (ii) 92,214 shares of common stock issuable to Ferrari Family Trust, for which Richard Ferrari is the trustee, upon the automatic conversion of a convertible note on the closing of the initial public offering of Tenon Medical, Inc. to occur on April 29, 2022.
F2 Richard Ferrari was granted an option to purchase 321,502 shares (or 160,751 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $3.53 (or $7.06 post-split) per share with a grant date of July 19, 2021, subject to monthly equal vesting over a three-year period commencing July 19, 2021.
F3 40,187 shares of common stock underlying stock options granted on July 19, 2021 have vested and are exercisable as of April 26, 2022.
F4 Richard Ferrari was granted an option to purchase 225,000 shares (or 112,500 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $2.60 (or $5.20 post-split) per share with a grant date of May 1, 2021, subject to monthly equal vesting over a three-year period commencing January 1, 2021.
F5 46,875 shares of common stock underlying stock options granted on May 1, 2021 have vested and are exercisable as of April 26, 2022.
F6 Option shares held by TCTIG, LLC for which Richard Ferrari has a 25% equity interest therein and has control over how TCTIG, LLC will vote 25% of the shares of common stock held by TCTIG, LLC. TCTIG, LLC was granted an option to purchase 109,353 shares (or 54,677 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $0.31 (or $0.62 post-split) per share with a grant date of June 19, 2014, which fully vested upon issuance.